Press Releases
This section of Viatris.com contains information that may not be suitable for use in all countries due to varied regulatory requirements, data protection requirements and practices or medical practices, and distinctions among product approval and commercial availability. The information contained in each news release or statement posted on this page is presented as of the date it was issued. The company undertakes no obligation to update the information for changes or subsequent events after the date it was originally issued.
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
- Jul 28, 2021Interchangeable Designation Allows Substitution at the Pharmacy Counter for Lantus® Across the U.S. to Help Increase Access to Medicines for People Living with Diabetes
- Jun 23, 2021Company Confident Evidence Regarding Only Remaining Claim Will Show Mylan's Actions Were Lawful and Pro-competitive
- May 6, 2021New company highlights patients, holistic approach to providing access to medicine, and path to further progress
- Mar 8, 2021Milestone reinforces Viatris' commitment to complex products and innovative solutions to help increase patient access
- Feb 9, 2021Viatris to host its inaugural virtual Investor Day on March 1, 2021, as previously announced
- Dec 11, 2020Initiative to Ensure Company is Set Up to Meet its Stated Commitments in Order to Deliver Sustainable Value to Patients, Customers, Shareholders and other Stakeholders
- Dec 7, 2020
New animations and materials featuring the Sesame Street Muppets address key emotions that families are feeling during the COVID-19 pandemic - Nov 23, 2020Tentative approval will help enhance access to WHO-recommended pediatric medicine and reduce the cost of HIV treatment for children in low- and middle-income countries
- Nov 16, 2020Combination of Mylan and Pfizer's Upjohn Business Focused on Access and Improved Patient Health
- Oct 30, 2020Pfizer Announces Record Date for the Proposed Transaction